Bright Minds Biosciences has a decent balance sheet, with roughly $40.3 million in cash. Click here to find out why I rate ...

Patients are growing increasingly interested in medical marijuana. As this interest grows, dermatologists must be prepared to ...

Perspective Therapeutics, Inc.’s CATX share price has dipped by 5.02%, which has investors questioning if this is right time ...

It's common knowledge that many use cannabis and natural products to treat pain symptoms, especially as the nation reckons ...

Lavender works faster than apps to reduce anxiety in 60 seconds or less by calming your nervous system through direct brain ...

Terpenes block a protein receptor called the adenosine a2a receptor ... “Importantly, terpenes, especially beta-caryophyllene, have Generally Recognized as Safe status by the FDA, which shows ...

Perspective Therapeutics, Inc. (NYSE:CATX – Get Free Report) has earned an average rating of “Buy” from the twelve brokerages that are presently covering the firm, MarketBeat reports. One equities ...

estrogen receptor alpha, estrogen receptor beta, glucocorticoid receptor, peroxisome proliferator-activated receptor gamma, and thyroid hormone receptor alpha. For each nuclear receptor, we selected a ...

Both function by binding to protein receptors on cells. The four primary receptors — alpha-1, alpha-2, beta-1, and beta-2 — are located in different body areas. The impact of norepinephrine and ...

The smell and flavor of cannabis come from compounds called terpenes. These are natural chemicals also found in many everyday ...

S&P 500 dips, tech stocks rally, Palantir secures NATO deal, Nvidia faces export restrictions, and major M&A ...